MiMedx Group, Inc. is an integrated developer, manufacturer and marketer of patent protected biomaterial-based products and is in the process of transitioning from a development-focused concern to an operating company focused on sales growth and profitability
The proceeds of the offering will be used to support the Company's launch of its first product, the Paradis Vaso Shield™, to facilitate further development activities related to progressing the Company's other products through regulatory clearance, as well as provide working capital and for general corporate purposes.
Yahoo Finance... ...
